Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05556473 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

F-Tryptophan PET/CT in Human Cancers

StatusCompleted
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial completed Show 5 more changesShow less
    • Final enrollment: 20 participants (planned 24)
    • Primary completion date changed from estimate of Dec 31, 2027 to Jul 18, 2025
    • Eligibility criteria expanded, about 20 words
    • Secondary endpoints: details revised at 2 of 2 entries
    • Site details revised
  2. Primary and study completion dates: Dec 31, 2026 to Dec 31, 2027v5
  3. Primary and study completion dates: Dec 31, 2024 to Dec 31, 2026v4
  4. Primary completion date: Jun 30, 2024 to Dec 31, 2024
    • Site contact updated
    v3
  5. Enrollment target: 19 to 24
    • Start date changed from estimate of Oct 2022 to Sep 29, 2022
    • Eligibility criteria expanded, about 39 words
    • Collaborators expanded, about 5 words
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Imaging procedures such as 1-(2-\[18F\]FLUOROETHYL)-L-Tryptophan PET/CT in patients with cancers may help doctors assess a patient's response to treatment and help plan the best treatment in the future. The purpose is to see if there can be a better differentiation of tumor and non-tumor tissue where the tumor tissue has a higher uptake of Tryptophan.
Trial Details
NCT Number NCT05556473
Lead Sponsor Barbara Ann Karmanos Cancer Institute
Collaborators: Washington University School of Medicine
Conditions
(from sponsor)		 Intracranial Glioma, Metastatic Brain Tumor, Breast Cancer, Neuroendocrine Tumors, Rectal Cancer
Related terms Brain Neoplasms, Breast Neoplasms, Neuroendocrine Tumors, Rectal Neoplasms
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov